Cargando…
Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure
Frailty is a geriatric syndrome of impaired resistance to stressors due to a decline in physiologic reserve. Frailty and cardiovascular disease (CVD) share a common biological pathway, and CVD may accelerate the development of frailty. Frailty is identified in 25% to 50% of patients with CVD, depend...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165117/ https://www.ncbi.nlm.nih.gov/pubmed/21949560 http://dx.doi.org/10.1007/s12170-011-0186-0 |
_version_ | 1782211088384786432 |
---|---|
author | Afilalo, Jonathan |
author_facet | Afilalo, Jonathan |
author_sort | Afilalo, Jonathan |
collection | PubMed |
description | Frailty is a geriatric syndrome of impaired resistance to stressors due to a decline in physiologic reserve. Frailty and cardiovascular disease (CVD) share a common biological pathway, and CVD may accelerate the development of frailty. Frailty is identified in 25% to 50% of patients with CVD, depending on the frailty scale used and the population studied. Frail patients with CVD, especially those undergoing invasive procedures or suffering from coronary artery disease and heart failure, are more likely to suffer adverse outcomes as compared to their non-frail counterparts. Five-meter gait speed is a simple and effective way of objectively measuring frailty in patients with CVD and should be incorporated in risk assessment. |
format | Online Article Text |
id | pubmed-3165117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Current Science Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-31651172011-09-21 Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure Afilalo, Jonathan Curr Cardiovasc Risk Rep Article Frailty is a geriatric syndrome of impaired resistance to stressors due to a decline in physiologic reserve. Frailty and cardiovascular disease (CVD) share a common biological pathway, and CVD may accelerate the development of frailty. Frailty is identified in 25% to 50% of patients with CVD, depending on the frailty scale used and the population studied. Frail patients with CVD, especially those undergoing invasive procedures or suffering from coronary artery disease and heart failure, are more likely to suffer adverse outcomes as compared to their non-frail counterparts. Five-meter gait speed is a simple and effective way of objectively measuring frailty in patients with CVD and should be incorporated in risk assessment. Current Science Inc. 2011-08-02 2011 /pmc/articles/PMC3165117/ /pubmed/21949560 http://dx.doi.org/10.1007/s12170-011-0186-0 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Afilalo, Jonathan Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure |
title | Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure |
title_full | Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure |
title_fullStr | Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure |
title_full_unstemmed | Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure |
title_short | Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure |
title_sort | frailty in patients with cardiovascular disease: why, when, and how to measure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165117/ https://www.ncbi.nlm.nih.gov/pubmed/21949560 http://dx.doi.org/10.1007/s12170-011-0186-0 |
work_keys_str_mv | AT afilalojonathan frailtyinpatientswithcardiovasculardiseasewhywhenandhowtomeasure |